HopeStage
Back to all studies
WithdrawnNCT06018727

Role Of Sensitivity to neuroEndocrine Systems in Social Decisions

This study has public registry information. It focuses on personality disorders and currently lists study information in the United States.

Personality disorders, Borderline personalityDrugFrom 18 Years to 45 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 45 years.

Listed locations
Chapel Hill, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: July 2024
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
University of North Carolina, Chapel Hill
Sponsor type
University
Study type
Drug
Intervention type
DIETARY_SUPPLEMENT, Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT06018727
Official title
Role Of Sensitivity to neuroEndocrine Systems in Social Decisions

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT06018727. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Withdrawn

Chapel Hill

Registry details
Registry conditions (original wording)

Borderline Personality Disorder

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of North Carolina, Chapel Hill, a university.

Does this study involve medication?

Yes. The study involves medication, including Hydrocortisone and Placebo.

Who can participate?

Listed age limits: 18 years to 45 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me